1 Spohr F, "Thrombolytics in CPR:current advantages in cardiopulmonary resuscitation" 71 : 291-296, 2005
2 Padosch SA, "Thrombolysis during cardio-pulmonary resuscitation" 51 : 516-532, 2002
3 Bedel SE, "Survival after cardiopulmonary resuscitation in the hospital" 309 : 569-76, 1983
4 Gurwitz JH, "Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction" 129 : 597-604, 1998
5 Kilic E, "Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice" 10 : 107-111, 1999
6 Robinson GR 2nd, "Postdischarge survival and func-tional status folowing in-hospital cardiopulmonary resuscitation" 105 : 991-6, 1994
7 Kim YH, "Nonproteolytic neuroprotec-tion by human recombinant tissue plasminogen activator" 284 : 647-650, 1999
8 Fischer M, "No-reflow after cardiac arest" 21 : 132-141, 1995
9 Gando S, "Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest" 77 : 278-282, 1997
10 Van de Werf F, "Management of acute myocardial infarction in patients presenting with ST segment elevation" 24 : 28-66, 2003
1 Spohr F, "Thrombolytics in CPR:current advantages in cardiopulmonary resuscitation" 71 : 291-296, 2005
2 Padosch SA, "Thrombolysis during cardio-pulmonary resuscitation" 51 : 516-532, 2002
3 Bedel SE, "Survival after cardiopulmonary resuscitation in the hospital" 309 : 569-76, 1983
4 Gurwitz JH, "Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction" 129 : 597-604, 1998
5 Kilic E, "Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice" 10 : 107-111, 1999
6 Robinson GR 2nd, "Postdischarge survival and func-tional status folowing in-hospital cardiopulmonary resuscitation" 105 : 991-6, 1994
7 Kim YH, "Nonproteolytic neuroprotec-tion by human recombinant tissue plasminogen activator" 284 : 647-650, 1999
8 Fischer M, "No-reflow after cardiac arest" 21 : 132-141, 1995
9 Gando S, "Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest" 77 : 278-282, 1997
10 Van de Werf F, "Management of acute myocardial infarction in patients presenting with ST segment elevation" 24 : 28-66, 2003
11 An SH, "Factors influencing the survival of patients with prehospital cardiac arest" 31 : 1059-1065, 2001
12 Newman DH, "Cardiac arrest and the role of thrombolytic agents" 35 : 472-480, 2000
13 Antman EM, "ACC/AHA guide-lines for the management of patients with ST-elevation myocardial infarction-executive summary:a report of the American Colege of Cardiology/American Heart Association Task Force on Practice Guidelines" 110 : 588-636, 204
14 Li X, "A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents" 70 : 31-36, 2006